SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-047612
Filing Date
2021-09-10
Accepted
2021-09-10 16:17:08
Documents
12
Period of Report
2021-09-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K_BID PRICE itrm-8k_20210907.htm   iXBRL 8-K 38001
  Complete submission text file 0001564590-21-047612.txt   174175

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA itrm-20210907.xsd EX-101.SCH 5685
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE itrm-20210907_lab.xml EX-101.LAB 20771
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itrm-20210907_pre.xml EX-101.PRE 12365
5 EXTRACTED XBRL INSTANCE DOCUMENT itrm-8k_20210907_htm.xml XML 3818
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 211247261
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences